Nicolet Advisory Services’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $501K | Buy |
1,085
+148
| +16% | +$68.4K | 0.04% | 216 |
|
|
2025
Q1 | $446K | Buy |
937
+234
| +33% | +$111K | 0.04% | 208 |
|
|
2024
Q4 | $288K | Buy |
703
+62
| +10% | +$25.4K | 0.03% | 302 |
|
|
2024
Q3 | $291K | Buy |
641
+28
| +5% | +$12.7K | 0.03% | 294 |
|
|
2024
Q2 | $301K | Buy |
613
+67
| +12% | +$32.9K | 0.03% | 276 |
|
|
2024
Q1 | $221K | Sell |
546
-51
| -9% | -$20.6K | 0.02% | 321 |
|
|
2023
Q4 | $249K | Buy |
597
+25
| +4% | +$10.4K | 0.03% | 280 |
|
|
2023
Q3 | $202K | Buy |
+572
| New | +$202K | 0.02% | 297 |
|